% | $
Quotes you view appear here for quick access.

Durata Therapeutics, Inc. (DRTX) Message Board

  • golongin2008 golongin2008 Nov 11, 2013 9:53 AM Flag

    ML ReAffirms Buy ant $14 Target

    Expects PDUFA date around May...ADCOM likely in Q1....EU filing by year end 2013....350mil peak sales by 2022...Attractive tax rate from IP transfer to Dutch subsidiary...Low market valuation versus peers...$14 price objective but could move to high teens on approval. Modest enterprise value. Hospitals are looking for a low cost means to treat infections on a longer term basis MRSA antibiotic....R&D could expand current opportunities for D. D for children...osteomyelitis....bronchoalveolar.lavage study for pneumonia...additional indications beyond skin infections etc. Low market value of 200 mil...

    Got a winner here gang IMHO...Patience then patients!

    SortNewest  |  Oldest  |  Most Replied Expand all replies
24.160.00(0.00%)Nov 17 4:00 PMEST